VEGFR2 is also preferentially expressed on the cell surface of CD133+ human glioma CSCs, whose viability, self-renewal, and tumourigenicity rely, at least in part, on signalling through the VEGF-VEGFR2–Neuropilin-1 axis15. The gene discussed is KDR; the disease is glioma.